US Patent

US11576894 — Combination therapy for the treatment of diabetes

Formulation · Assigned to Janssen Pharmaceutica NV · Expires 2030-07-06 · 4y remaining

Vulnerability score 56/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a combination therapy for treating and preventing glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X.

USPTO Abstract

The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is further directed to pharmaceutical compositions for the co-therapy and methods described herein.

Drugs covered by this patent

Patent Metadata

Patent number
US11576894
Jurisdiction
US
Classification
Formulation
Expires
2030-07-06
Drug substance claim
No
Drug product claim
Yes
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.